Bembenek; Scott D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bembenek; Scott D..The latest application filed is for "inhibitors of bruton's tyrosine kinase and methods of their use".

Company Profile

9.12.12

Bembenek; Scott D. - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibitors of Bruton's tyrosine kinase and methods of their use Grant 11,319,329 - Arora , et al. May 3, 2	2022-05-03
Inhibitors Of Bruton's Tyrosine Kinase And Methods Of Their Use App 20210101910 - Arora; Nidhi ; et al.	2021-04-08
Inhibitors of Bruton's tyrosine kinase and method of their use Grant 10,934,310 - Arora , et al. March 2, 2	2021-03-02
Inhibitors of Bruton's tyrosine kinase and methods of their use Grant 10,822,348 - Arora , et al. November 3, 2	2020-11-03
Inhibitors of Bruton's tyrosine kinase and method of their use Grant 10,800,792 - Arora , et al. October 13, 2	2020-10-13
Inhibitors of Bruton's tyrosine kinase and method of their use Grant 10,717,745 - Arora , et al.	2020-07-21
Inhibitors of Bruton's tyrosine kinase and methods of their use Grant 10,689,396 - Arora , et al.	2020-06-23
Inhibitors Of Bruton's Tyrosine Kinase And Method Of Their Use App 20190284203 - Arora; Nidhi ; et al.	2019-09-19
Inhibitors Of Bruton's Tyrosine Kinase And Method Of Their Use App 20190284204 - Arora; Nidhi ; et al.	2019-09-19
Inhibitors Of Bruton's Tyrosine Kinase And Method Of Their Use App 20190276471 - Arora; Nidhi ; et al.	2019-09-12
Inhibitors Of Bruton's Tyrosine Kinase And Method Of Their Use App 20170283430 - ARORA; Nidhi ; et al.	2017-10-05
Inhibitors Of Bruton's Tyrosine Kinase And Method Of Their Use App 20170283431 - ARORA; Nidhi ; et al.	2017-10-05
Quinazolinones as prolyl hydroxylase inhibitors Grant 8,937,078 - Bembenek , et al. January 20, 2	2015-01-20
Aryl-substituted bridged or fused diamines as modulators of leukotriene A.sub.4 hydrolase Grant 8,367,719 - Bacani , et al. February 5, 2	2013-02-05
Aryl-substituted bridged or fused diamines as modulators of leukotriene A ydrolase Grant 8,344,008 - Bacani , et al. January 1, 2	2013-01-01
Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase App 20110263639 - Bacani; Genesis M. ; et al.	2011-10-27
Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase App 20110257153 - Bacani; Genesis M. ; et al.	2011-10-20
Aryl-substituted bridged or fused diamines as modulators of leukotriene A.sub.4 hydrolase Grant 7,935,725 - Bembenek , et al. May 3, 2	2011-05-03
Quinazolinones As Prolyl Hydroxylase Inhibitors App 20100204226 - Bembenek; Scott D. ; et al.	2010-08-12
Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase App 20090111794 - Bacani; Genesis M. ; et al.	2009-04-30
LTA4H modulators App 20050043378 - Axe, Frank U. ; et al.	2005-02-24
LTA4H Modulators App 20050043379 - Axe, Frank U. ; et al.	2005-02-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.